Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,819 | 245,735 | 108,352 | 125,699 | 94,851 |
| Marketable Securities | 108,303 | N/A | N/A | N/A | N/A |
| Receivables | 1,764 | 1,764 | 4,706 | 882 | 1,012 |
| TOTAL | $234,399 | $249,697 | $115,241 | $128,624 | $96,973 |
| Non-Current Assets | |||||
| PPE Net | 62 | 97 | 135 | 173 | 212 |
| Other Non-Current Assets | 134 | 156 | 338 | 1,390 | 1,638 |
| TOTAL | $196 | $253 | $473 | $1,563 | $1,850 |
| Total Assets | $234,595 | $249,950 | $115,714 | $130,187 | $98,823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,012 | 4,634 | 2,375 | 5,629 | 3,666 |
| Accrued Expenses | 12,867 | 7,131 | 8,384 | 6,860 | 4,950 |
| TOTAL | $19,933 | $11,818 | $10,978 | $12,984 | $9,361 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 76 | 91 | 106 | 0 | 0 |
| TOTAL | $76 | $91 | $106 | $N/A | $N/A |
| Total Liabilities | $20,009 | $11,909 | $11,084 | $12,984 | $9,361 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,568 | 89,502 | 50,256 | 49,688 | 41,606 |
| Common Shares | 90 | 89 | 50 | 50 | 42 |
| Retained earnings | -539,641 | -514,191 | -495,602 | -480,526 | -463,048 |
| Other shareholders' equity | 1 | 0 | 0 | 0 | 0 |
| TOTAL | $214,586 | $238,041 | $104,630 | $117,203 | $89,462 |
| Total Liabilities And Equity | $234,595 | $249,950 | $115,714 | $130,187 | $98,823 |